Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Micke

Showing results (111-120 of 165) with videos related to

Pageof 17
Sort By:
Cancer Research|December 9, 2020
Targeting MARCO and IL37R on Immunosuppressive Macrophages in Lung Cancer Blocks Regulatory T Cells and Supports Cytotoxic Lymphocyte FunctionLinnéa La Fleur, Johan Botling, Fei He, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 15, 2019
Prognostic Impact of Tumor Cell Programmed Death Ligand 1 Expression and Immune Cell Infiltration in NSCLCKarolina Edlund, Katrin Madjar, Johanna S M Mattsson, et al.
Cancer Medicine|June 4, 2020
Comprehensive analysis of RNA binding motif protein 3 (RBM3) in non-small cell lung cancerAnnette Salomonsson, Patrick Micke, Johanna S M Mattsson, et al.
Cancers|November 13, 2021
The Immune Landscape of Colorectal CancerArtur Mezheyeuski, Patrick Micke, Alfonso Martín-Bernabé, et al.
Plos One|December 8, 2016
Epsin Family Member 3 and Ribosome-Related Genes Are Associated with Late Metastasis in Estrogen Receptor-Positive Breast Cancer and Long-Term Survival in Non-Small Cell Lung Cancer Using a Genome-Wide Identification and Validation StrategyBirte Hellwig, Katrin Madjar, Karolina Edlund, et al.
Oncotarget|December 25, 2015
The protein kinase LKB1 negatively regulates bone morphogenetic protein receptor signalingErna Raja, Kalliopi Tzavlaki, Robin Vuilleumier, et al.
Lung Cancer (Amsterdam, Netherlands)|March 20, 2019
Mutation patterns in a population-based non-small cell lung cancer cohort and prognostic impact of concomitant mutations in KRAS and TP53 or STK11Linnéa La Fleur, Elin Falk-Sörqvist, Patrik Smeds, et al.
Cell Communication and Signaling : CCS|January 16, 2026
In situ mapping of activated PDGFRβ defines a prognostic discrepancy between histological subtypes of NSCLCAmanda Lindberg, Louise Hellberg, Anaïs Grandon, et al.
Cell Death and Differentiation|December 1, 2020
Identification and functional characterization of new missense SNPs in the coding region of the TP53 geneFlora Doffe, Vincent Carbonnier, Manon Tissier, et al.
Cancer Letters|June 14, 2020
ASCL1 promotes tumor progression through cell-autonomous signaling and immune modulation in a subset of lung adenocarcinomaNaoya Miyashita, Masafumi Horie, Yu Mikami, et al.
Pageof 17

Showing results (111-120 of 165) with videos related to

Sort By:
Pageof 17
Cancer Research|December 9, 2020
Targeting MARCO and IL37R on Immunosuppressive Macrophages in Lung Cancer Blocks Regulatory T Cells and Supports Cytotoxic Lymphocyte FunctionLinnéa La Fleur, Johan Botling, Fei He, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 15, 2019
Prognostic Impact of Tumor Cell Programmed Death Ligand 1 Expression and Immune Cell Infiltration in NSCLCKarolina Edlund, Katrin Madjar, Johanna S M Mattsson, et al.
Cancer Medicine|June 4, 2020
Comprehensive analysis of RNA binding motif protein 3 (RBM3) in non-small cell lung cancerAnnette Salomonsson, Patrick Micke, Johanna S M Mattsson, et al.
Cancers|November 13, 2021
The Immune Landscape of Colorectal CancerArtur Mezheyeuski, Patrick Micke, Alfonso Martín-Bernabé, et al.
Plos One|December 8, 2016
Epsin Family Member 3 and Ribosome-Related Genes Are Associated with Late Metastasis in Estrogen Receptor-Positive Breast Cancer and Long-Term Survival in Non-Small Cell Lung Cancer Using a Genome-Wide Identification and Validation StrategyBirte Hellwig, Katrin Madjar, Karolina Edlund, et al.
Oncotarget|December 25, 2015
The protein kinase LKB1 negatively regulates bone morphogenetic protein receptor signalingErna Raja, Kalliopi Tzavlaki, Robin Vuilleumier, et al.
Lung Cancer (Amsterdam, Netherlands)|March 20, 2019
Mutation patterns in a population-based non-small cell lung cancer cohort and prognostic impact of concomitant mutations in KRAS and TP53 or STK11Linnéa La Fleur, Elin Falk-Sörqvist, Patrik Smeds, et al.
Cell Communication and Signaling : CCS|January 16, 2026
In situ mapping of activated PDGFRβ defines a prognostic discrepancy between histological subtypes of NSCLCAmanda Lindberg, Louise Hellberg, Anaïs Grandon, et al.
Cell Death and Differentiation|December 1, 2020
Identification and functional characterization of new missense SNPs in the coding region of the TP53 geneFlora Doffe, Vincent Carbonnier, Manon Tissier, et al.
Cancer Letters|June 14, 2020
ASCL1 promotes tumor progression through cell-autonomous signaling and immune modulation in a subset of lung adenocarcinomaNaoya Miyashita, Masafumi Horie, Yu Mikami, et al.
Pageof 17